These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 23421781)
1. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS Trials; 2013 Feb; 14():53. PubMed ID: 23421781 [TBL] [Abstract][Full Text] [Related]
2. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS Trials; 2012 Aug; 13():156. PubMed ID: 22937736 [TBL] [Abstract][Full Text] [Related]
3. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial. Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial. Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252 [TBL] [Abstract][Full Text] [Related]
5. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial. Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748 [TBL] [Abstract][Full Text] [Related]
6. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887 [TBL] [Abstract][Full Text] [Related]
8. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial. Ruffles TJC; Goyal V; Marchant JM; Masters IB; Yerkovich S; Buntain H; Cook A; Schultz A; Upham JW; Champion A; Versteegh L; Chang AB Lancet Respir Med; 2021 Oct; 9(10):1121-1129. PubMed ID: 34048716 [TBL] [Abstract][Full Text] [Related]
9. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin for acute lower respiratory tract infections. Laopaiboon M; Panpanich R; Swa Mya K Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001954. PubMed ID: 25749735 [TBL] [Abstract][Full Text] [Related]
11. Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial. Chang AB; Morgan LC; Duncan EL; Chatfield MD; Schultz A; Leo PJ; McCallum GB; McInerney-Leo AM; McPhail SM; Zhao Y; Kruljac C; Smith-Vaughan HC; Morris PS; Marchant JM; Yerkovich ST; Cook AL; Wurzel D; Versteegh L; O'Farrell H; McElrea MS; Fletcher S; D'Antoine H; Stroil-Salama E; Robinson PJ; Grimwood K BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35534039 [TBL] [Abstract][Full Text] [Related]